| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025336386 |
| P356 | DOI | 10.1186/CC2418 |
| P932 | PMC publication ID | 468887 |
| P698 | PubMed publication ID | 15153235 |
| P5875 | ResearchGate publication ID | 8553553 |
| P50 | author | Daniel De Backer | Q38327636 |
| Pierre Asfar | Q89794638 | ||
| Peter Radermacher | Q112381157 | ||
| P2093 | author name string | Andreas Meier-Hellmann | |
| Samir G Sakka | |||
| P2860 | cites work | Pro/con clinical debate: Hydroxyethylstarches should be avoided in septic patients | Q24795408 |
| Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients | Q24803954 | ||
| Bench-to-bedside review: Cytopathic hypoxia | Q24807180 | ||
| Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock | Q28371456 | ||
| Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock | Q30711418 | ||
| Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock | Q31056350 | ||
| Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial | Q31832586 | ||
| Could anti-inflammatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients? | Q33925700 | ||
| Part 6: advanced cardiovascular life support. Section 6: pharmacology II: agents to optimize cardiac output and blood pressure. European Resuscitation Council | Q34026148 | ||
| The mesenteric hemodynamic response to circulatory shock: an overview. | Q34240538 | ||
| The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series | Q34340908 | ||
| Opening the microcirculation: can vasodilators be useful in sepsis? | Q34810464 | ||
| The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients | Q36838745 | ||
| Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response | Q39833728 | ||
| The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients | Q41430318 | ||
| The effects of prostacyclin on gastric intramucosal pH in patients with septic shock | Q42277793 | ||
| Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? | Q42601060 | ||
| Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock | Q43513379 | ||
| The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis. | Q43541004 | ||
| Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock | Q43617591 | ||
| Effect of dopexamine on hepatic metabolic activity in patients with septic shock. | Q43626208 | ||
| Increased ileal-mucosal-arterial PCO2 gap is associated with impaired villus microcirculation in endotoxic pigs | Q43634392 | ||
| Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation? | Q43652073 | ||
| Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients | Q43707158 | ||
| Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock | Q43726999 | ||
| Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. | Q43791850 | ||
| Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis | Q43825500 | ||
| Beneficial effects of short-term vasopressin infusion during severe septic shock | Q43901842 | ||
| Splanchnic and total body oxygen consumption differences in septic and injured patients | Q43928417 | ||
| Terlipressin for norepinephrine-resistant septic shock | Q43960661 | ||
| Microvascular blood flow is altered in patients with sepsis | Q44045816 | ||
| Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients | Q44048533 | ||
| Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. | Q44052241 | ||
| Terlipressin for haemodynamic support in septic patients: a double-edged sword? | Q44194825 | ||
| Patient with a sudden drop in blood pressure | Q44289487 | ||
| Gastric capnometry with air-automated tonometry predicts outcome in critically ill patients | Q44308915 | ||
| Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study | Q44430966 | ||
| High-dose vasopressin is not superior to norepinephrine in septic shock* | Q44647389 | ||
| Does gastric tonometry monitor splanchnic perfusion? | Q44901757 | ||
| N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. | Q51368693 | ||
| Crystalloids vs. colloids in fluid resuscitation: a systematic review. | Q51476630 | ||
| Epinephrine impairs splanchnic perfusion in septic shock. | Q51546880 | ||
| The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. | Q51553363 | ||
| Increasing splanchnic blood flow in the critically III. | Q51587994 | ||
| N-acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventilation. | Q51608767 | ||
| Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. | Q51620665 | ||
| Dopexamine hydrochloride in septic shock. | Q53007675 | ||
| Effect of vasoactive treatment on the relationship between mixed venous and regional oxygen saturation. | Q54072773 | ||
| The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. | Q54191284 | ||
| RETRACTED: The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients | Q56766002 | ||
| Abnormalities of Gastric Mucosal Oxygenation in Septic Shock | Q60364372 | ||
| Effects of Dobutamine on Gastric Mucosal Perfusion and Hepatic Metabolism in Patients with Septic Shock | Q61369100 | ||
| A Dobutamine Test Can Disclose Hepatosplanchnic Hypoperfusion in Septic Patients | Q64127223 | ||
| Does Hepato-splanchnic V˙o2/Do2Dependency Exist in Critically Ill Septic Patients? | Q64127317 | ||
| Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions | Q68194061 | ||
| Multiple-organ-failure syndrome | Q68793720 | ||
| Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure | Q70577486 | ||
| Effect of stored-blood transfusion on oxygen delivery in patients with sepsis | Q70736891 | ||
| N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock | Q71255358 | ||
| Intermittent hemodialysis in critically ill patients with multiple organ dysfunction syndrome is associated with intestinal intramucosal acidosis | Q71703901 | ||
| Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green | Q71729329 | ||
| Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creatinine clearance | Q71906940 | ||
| Protecting the gut and the liver in the critically ill: effects of dopexamine | Q72415476 | ||
| The gastrointestinal tract. The canary of the body? | Q72889409 | ||
| Regional blood flow and oxygen transport in septic shock | Q72920953 | ||
| Vasopressin deficiency contributes to the vasodilation of septic shock | Q73120268 | ||
| Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine | Q73148728 | ||
| Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study | Q73182846 | ||
| Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: a prospective, randomized study | Q73219079 | ||
| Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock | Q73228495 | ||
| Effect of a dopexamine-induced increase in cardiac index on splanchnic hemodynamics in septic shock | Q73536739 | ||
| Vasopressin pressor hypersensitivity in vasodilatory septic shock | Q73617085 | ||
| The effect of dobutamine infusion on splanchnic blood flow and oxygen transport in patients with acute pancreatitis | Q73683344 | ||
| Do fluid administration and reduction in norepinephrine dose improve global and splanchnic haemodynamics? | Q74004140 | ||
| Gastric-arterial PCO2 gradient does not reflect systemic and splanchnic hemodynamics or oxygen transport after cardiac surgery | Q74051701 | ||
| Volume expansion using pentastarch does not change gastric-arterial CO2 gradient or gastric intramucosal pH in patients who have sepsis syndrome | Q74096199 | ||
| Splanchnic perfusion during hemodialysis: evidence for marginal tissue perfusion | Q74166270 | ||
| What about vasopressin? | Q77064601 | ||
| N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study | Q77972995 | ||
| Nitroglycerin in septic shock after intravascular volume resuscitation | Q78494402 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | intestinal epithelium | Q509615 |
| hemodynamics | Q1642137 | ||
| septic shock | Q1765564 | ||
| liver | Q9368 | ||
| splanchnic circulation | Q71230698 | ||
| P304 | page(s) | 170-9 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock | |
| P478 | volume | 8 |
| Q36261528 | Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury |
| Q37623067 | Bench-to-bedside review: Beta-adrenergic modulation in sepsis. |
| Q24812256 | Blood flow, not hypoxia, determines intramucosal PCO2. |
| Q43813602 | Catecholamine dosing and survival in adult intensive care unit patients |
| Q34714199 | Comparison of the effects of aging and IL-6 on the hepatic inflammatory response in two models of systemic injury: scald injury versus i.p. LPS administration |
| Q38345635 | Controversies regarding choice of vasopressor therapy for management of septic shock in animals |
| Q33235038 | Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study [NCT00134212]. |
| Q37820373 | Interpretation of blood pressure signal: physiological bases, clinical relevance, and objectives during shock states. |
| Q79687121 | Levosimendan in septic shock: another piece in the puzzle, but many pieces are still lacking |
| Q45122666 | Main determinants of liver microcirculation during systemic inflammation |
| Q38634821 | Personalizing blood pressure management in septic shock |
| Q37506509 | Poisoning-related bowel infarction: characteristics and outcomes |
| Q88711560 | Shock Management for Cardio-surgical ICU Patients - The Golden Hours |
| Q35562058 | Thoracic epidural anesthesia: Effects on splanchnic circulation and implications in Anesthesia and Intensive care |
| Q37962808 | Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis |
| Q84568726 | [Perioperative protection of the gastrointestinal tract] |
Search more.